Welcome to Drug Target Review. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Whitepapers
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Cell,Culture,With,Multichannel,Pipettes
      Designing targeted assays for clinical success from the start
    • Medical,Scientist,Loading,Samples,In,Robot,Machine,For,Biochemical,Automatic
      Discovery is changing – and automation leads the way
    • Image
      World ADC 2026: where antibody-drug conjugates are heading
  • Webinars
  • Whitepapers
  • Reports
  • More navigation items

A to Z subjects

Find stories by subject. Use the A-Z options to view other subjects.

  • A to Z subjects
  • A to Z contributors
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • 0-9
  • All
F
  • Fabrice Chouraqui
  • FairJourney Biologics S.A.
  • Fauna Bio
  • Fernando Ferrer (data engineering leader and investor in Meta-Flux)
  • fibrosis (scarring)
  • Flagship Pioneering
  • Flinders University
  • Florida A&M University College of Pharmacy and Pharmaceutical Sciences
  • Florida Atlantic University (FAU)
  • Florida University
  • Flow Cytometry
  • Flow Robotics
  • Food and Drug Administration (FDA)
  • FORESIGHT Consortium
  • Formulation
  • Fragile X Syndrome
  • Fralin Biomedical Research Institute at VTC
  • Francis Crick Institute
  • Frank McKeon
  • Fred Grossman (President and Chief Medical Officer at Coya Therapeutics)
  • Fred Hutchinson Cancer Center
  • Frederick G. L. Huetwell (Professor of Cardiovascular Medicine at U-M Medical School)
  • Frontier Bio
  • Fudan University
  • Fujita Health University
  • Funding
  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud